Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

City of Hope Takes a Commercial Product License to Use ProBioGen’s AGE1.CR® Vaccine Manufacturing Platform

b3cnewswireJune 10, 2021

Tag: AGE1.CR® , Vaccine , ProBioGen

PharmaSources Customer Service